Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Vergoulas

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Hippokratia|July 8, 2009
Antihypertensive agents and renal transplantationG Vergoulas
Hippokratia|December 17, 2009
Brain dead donor kidneys are immunologically active: is intervention justified?G Vergoulas, P Boura, G Efstathiadis
Hippokratia|July 8, 2009
Leptin as a cardiovascular risk factorG Efstratiadis, C Nikolaidou, G Vergoulas
Hippokratia|July 8, 2009
Interventional nephrology: a new subspecialty of nephrologyG Efstratiadis, I Platsas, P Koukoudis, et al.
Hippokratia|October 17, 2008
Cardio-renal anemia syndromeG Efstratiadis, D Konstantinou, I Chytas, et al.
Hippokratia|December 17, 2009
Renal fibrosisG Efstratiadis, M Divani, E Katsioulis, et al.
Hippokratia|October 29, 2010
P2X(7) receptor at the heart of diseaseEi Vasileiou, R M Montero, C M Turner, et al.
Hippokratia|July 8, 2009
Rhabdomyolysis updatedG Efstratiadis, A Voulgaridou, D Nikiforou, et al.
Hippokratia|November 17, 2011
Quality of life survey and palliative care in lung cancer patientsL Zoganas, G Bablekos, M Maiwand, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 9, 2000
Combined treatment of hypercholesterolemia of renal transplant allograft recipients with fluvastatin and gemfibrozilG Vergoulas, G Miserlis, F Solonaki, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Hippokratia|July 8, 2009
Antihypertensive agents and renal transplantationG Vergoulas
Hippokratia|December 17, 2009
Brain dead donor kidneys are immunologically active: is intervention justified?G Vergoulas, P Boura, G Efstathiadis
Hippokratia|July 8, 2009
Leptin as a cardiovascular risk factorG Efstratiadis, C Nikolaidou, G Vergoulas
Hippokratia|July 8, 2009
Interventional nephrology: a new subspecialty of nephrologyG Efstratiadis, I Platsas, P Koukoudis, et al.
Hippokratia|October 17, 2008
Cardio-renal anemia syndromeG Efstratiadis, D Konstantinou, I Chytas, et al.
Hippokratia|December 17, 2009
Renal fibrosisG Efstratiadis, M Divani, E Katsioulis, et al.
Hippokratia|October 29, 2010
P2X(7) receptor at the heart of diseaseEi Vasileiou, R M Montero, C M Turner, et al.
Hippokratia|July 8, 2009
Rhabdomyolysis updatedG Efstratiadis, A Voulgaridou, D Nikiforou, et al.
Hippokratia|November 17, 2011
Quality of life survey and palliative care in lung cancer patientsL Zoganas, G Bablekos, M Maiwand, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 9, 2000
Combined treatment of hypercholesterolemia of renal transplant allograft recipients with fluvastatin and gemfibrozilG Vergoulas, G Miserlis, F Solonaki, et al.
Pageof 2